Description MELA Sciences, formerly Electro-Optical Sciences, can detect whether that mole is a sign of a more serious medical condition -- melanoma. The company's lead product is a hand-held imaging device called MelaFind, which captures images of suspicious skin lesions, compares them to other malignant and benign lesions stored in a database, and provides information about whether they should be biopsied. MelaFind is in pivotal clinical trials for its ability to detect skin cancer at an early stage. MELA Sciences is seeking FDA approval, so that it can begin commercially marketing the point-of-care product to primary care physicians, dermatologists, and plastic surgeons in the US and through partnerships abroad.